| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2000;119:581-587
© 2000 Mosby, Inc.
CARDIOPULMONARY SUPPORT AND PHYSIOLOGY |
From the Department of Thoracic and Cardiovascular Surgery, Heart Center North Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany.
Supported by the German Association of Organ Recipients (Registered Association).
Address for reprints: A. El-Banayosy, MD, Herzzentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie, Georgstr 11, D-32545 Bad Oeynhausen, Germany (E-mail: abanayosy{at}hdz-nrw.ruhr-uni-bochum.de ).
Objective: Long-term mechanical circulatory support as a bridge-to-transplantation procedure and bridge to recovery is of increasing importance. The implantable left ventricular assist devices, Novacor N100 left ventricular assist system (Baxter Healthcare Corporation, Berkeley, Calif) and TCI HeartMate vented electric left ventricular assist system (Thermo Cardiosystems Inc, Woburn, Mass), have proved to be efficient devices in bridge-to-transplantation settings and for prolonged support. The two systems were compared with regard to reliability and morbidity.
Methods: Between October 1996 and March 1998, a prospective, single-center study was done that included 40 patients, 20 of whom were treated with the Novacor system and 20 of whom were treated with the HeartMate device. The diseases were mainly dilated cardiomyopathy (13/9) and ischemic cardiomyopathy (6/10). There were no statistically significant differences between the two groups regarding age, sex, preoperative clinical blood chemistry values, hemodynamic data, or risk factors.
Results: There were no statistically significant differences between the two groups with regard to postoperative hemodynamics, organ recovery, out-of-hospital support, and survival to heart transplantation. Mean duration of support was 235.3 ± 210 days for the Novacor group and 174.6 ± 175 days for the HeartMate group and mean out-of-hospital support was 241 ± 179 days and 166 ± 152 days for the two groups, respectively. Neurologic complications occurred significantly more often among the Novacor group, whereas the HeartMate group had a higher prevalence of infections and technical problems, which was statistically significant. Survival to transplantation was 65% for the Novacor group and 60% for the HeartMate group.
Conclusions: Most patients had organ recovery with left ventricular assist system support, and a considerable number of patients in both groups underwent transplantation. However, both devices need revision to address the current problems, that is, thromboembolism for the Novacor device and infection and reliability for the HeartMate device.
This article has been cited by other articles:
|
|
 |
|
  E. A. Genovese, M. A. Dew, J. J. Teuteberg, M. A. Simon, J. Kay, M. P. Siegenthaler, J. K. Bhama, C. A. Bermudez, K. L. Lockard, S. Winowich, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann. Thorac. Surg., October 1, 2009; 88(4): 1162 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. D. Pagani, L. W. Miller, S. D. Russell, K. D. Aaronson, R. John, A. J. Boyle, J. V. Conte, R. C. Bogaev, T. E. MacGillivray, Y. Naka, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 312 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garatti, G. Bruschi, T. Colombo, C. Russo, M. Lanfranconi, F. Milazzo, M. Frigerio, and E. Vitali Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 275 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Copeland, R. G. Smith, R. K. Bose, P. H. Tsau, P. E. Nolan, and M. J. Slepian Risk Factor Analysis for Bridge to Transplantation With the CardioWest Total Artificial Heart Ann. Thorac. Surg., May 1, 2008; 85(5): 1639 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsukui, A. Abla, J. J. Teuteberg, D. M. McNamara, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Cerebrovascular accidents in patients with a ventricular assist device J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 114 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Wieselthaler, M. Riedl, H. Schima, O. Wagner, W. Waldhausl, E. Wolner, A. Luger, and M. Clodi Endocrine function is not impaired in patients with a continuous MicroMed-DeBakey axial flow pump J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 2 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Clegg, D. A. Scott, E. Loveman, J. L. Colquitt, P. Royle, and J. Bryant Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation Eur. Heart J., December 2, 2006; 27(24): 2929 - 2938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Potapov, M. J. Jurmann, T. Drews, M. Pasic, M. Loebe, Y. Weng, and R. Hetzer Patients supported for over 4 years with left ventricular assist devices Eur J Heart Fail, November 1, 2006; 8(7): 756 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Wilhelm, D. Hammel, C. Schmid, A. Rhode, T. Kaan, M. Rothenburger, J. Stypmann, M. Schafers, C. Schmidt, H. A. Baba, et al. Long-term support of 9 patients with the DeBakey VAD for more than 200 days J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1122 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Copeland, R. G. Smith, F. A. Arabia, P. E. Nolan, G. K. Sethi, P. H. Tsau, D. McClellan, M. J. Slepian, and the CardioWest Total Artificial Heart Investigator Cardiac Replacement with a Total Artificial Heart as a Bridge to Transplantation N. Engl. J. Med., August 26, 2004; 351(9): 859 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Houel, E. Mazoyer, B. Boval, M. Kirsch, E. Vermes, L. Drouet, and D. Y. Loisance Platelet activation and aggregation profile in prolonged external ventricular support J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 197 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Doi, L. A. R. Golding, A. L. Massiello, M. W. Kopcak Jr, R. L. Gerhart, S. Schenk, M. Inoue, Y. Ootaki, and K. Fukamachi Preclinical readiness testing of the arrow international CorAide left ventricular assist system Ann. Thorac. Surg., June 1, 2004; 77(6): 2103 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Morgan, R. John, V. Rao, A. D. Weinberg, B. J. Lee, P. A. Mazzeo, M. R. Flannery, J. M. Chen, M. C. Oz, and Y. Naka Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1309 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Granfeldt, B. Koul, L. Wiklund, B. Peterzen, U. Lonn, A. Babic, and H. C. Ahn Risk factor analysis of Swedish Left Ventricular Assist Device (LVAD) patients Ann. Thorac. Surg., December 1, 2003; 76(6): 1993 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Banayosy, L. Arusoglu, L. Kizner, M. Morshuis, G. Tenderich, W. E. Pae Jr, and R. Korfer Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure Ann. Thorac. Surg., May 1, 2003; 75(5): 1469 - 1475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kono, K. Nishimura, T. Nishina, S. Yuasa, K. Ueyama, C. Hamada, T. Akamatsu, and M. Komeda Autosynchronized systolic unloading during left ventricular assist with a centrifugal pump J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Russo, A. M. De Biase, G. Bruschi, S. Agati, and E. Vitali Successful intraventricular thrombolysis during ventricular assist device support Ann. Thorac. Surg., May 1, 2002; 73(5): 1628 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Minami Surgical Treatments for Endstage Heart Failure Due to Dilated Cardiomyopathy Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 159 - 166. [Full Text] [PDF]
|
|
|
|
|
|
C. C. Canver and J. Chanda Heart transplantation Ann. Thorac. Surg., August 1, 2001; 72(2): 658 - 660. [Full Text] [PDF]
|
|
|
|
|
|
L. R. McBride, K. S. Naunheim, A. C. Fiore, R. G. Johnson, D. A. Moroney, J. A. Brannan, and M. T. Swartz Risk analysis in patients bridged to transplantation Ann. Thorac. Surg., June 1, 2001; 71(6): 1839 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Banayosy, R. Korfer, L. Arusoglu, L. Kizner, M. Morshuis, H. Milting, G. Tenderich, O. Fey, and K. Minami Device and patient management in a bridge-to-transplant setting Ann. Thorac. Surg., March 1, 2001; 71 (2007): S98 - S102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Niklason and R. Langer Prospects for Organ and Tissue Replacement JAMA, February 7, 2001; 285(5): 573 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L.C. Cheung, W.-K. Au, H. H.C. Cheung, C. S.W. Chiu, and W.-T. Lee Coronary artery fistulas: long-term results of surgical correction Ann. Thorac. Surg., January 1, 2001; 71(1): 190 - 195. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
